Johnson & Johnson (JNJ) | Enterprise Value to EBITDA (EV/EBITDA)
Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Johnson & Johnson, EBITDA calculation
USD $ in millions
| 12 months ended | Dec 30, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
|---|---|---|---|---|---|---|
| Net earnings attributable to Johnson & Johnson | 10,853 | 9,672 | 13,334 | 12,266 | 12,949 | |
| Net loss attributable to noncontrolling interest | (339) | – | – | – | – | |
| Interest expense, net of portion capitalized | 532 | 571 | 455 | 451 | 435 | |
| Income tax expense (benefit) | 3,261 | 2,689 | 3,613 | 3,489 | 3,980 | |
| Earnings before interest and tax (EBIT) | 14,307 | 12,932 | 17,402 | 16,206 | 17,364 | |
| Depreciation and amortization of property and intangibles | 3,666 | 3,158 | 2,939 | 2,774 | 2,832 | |
| Earnings before interest, tax, depreciation and amortization (EBITDA) | 17,973 | 16,090 | 20,341 | 18,980 | 20,196 |
| Item | Description | The company |
|---|---|---|
| EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | Johnson & Johnson's EBITDA declined from 2010 to 2011 but then slightly increased from 2011 to 2012. |
ADVERTISEMENT
EV to EBITDA Ratio, Current
Johnson & Johnson, current EV/EBITDA
| Johnson & Johnson | Health Care | |
|---|---|---|
| Selected Financial Data (USD $ in millions) | ||
| Enterprise value (EV) | 241,092 | |
| Earnings before interest, tax, depreciation and amortization (EBITDA) | 17,973 | |
| Ratio | ||
| EV/EBITDA | 13.41 | 10.07 |
If company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
ADVERTISEMENT
EV to EBITDA Ratio, Historical
Johnson & Johnson, EV/EBITDA calculation
| Dec 30, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Enterprise value (EV)1 | 208,219 | 166,071 | 152,243 | 169,561 | 150,194 | |
| Earnings before interest, tax, depreciation and amortization (EBITDA)2 | 17,973 | 16,090 | 20,341 | 18,980 | 20,196 | |
| EV/EBITDA, Comparison to Industry | ||||||
| Johnson & Johnson3 | 11.59 | 10.32 | 7.48 | 8.93 | 7.44 | |
| Industry, Health Care | 9.28 | 7.90 | 8.16 | 7.35 | 7.02 | |
2012 Calculations
3 EV/EBITDA = EV ÷ EBITDA
= 208,219 ÷ 17,973 = 11.59
| Ratio | Description | The company |
|---|---|---|
| EV/EBITDA | EV/EBITDA is a valuation indicator for the overall company rather than common stock. | Johnson & Johnson's EV/EBITDA ratio increased from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT





